Cytodyn is a poorly run company with people at the helm with no business being there, a severe lack of funding that is quickly drying up, a couple failed trials and a lot of bad faith, and no one willing to cover their updates outside of paid for pump sources like emerginggrowth or proactive, not a movie. Leronlimab is a real failure not a subplot for the underdog making a huge comeback and saving the day.
If people take a depressive veiw of CYDY walking away will not bring relief as there will be another company to be depressed about. If one has no optimism one should look inward for the solution.
Market Data 
Markets 
AI
